Orvosi Dinitrogén-Oxid Sol (Nitrous Oxide)

Nitrous oxide produces analgesia and sedation by antagonizing NMDA receptors and modulating opioid pathways in the central nervous system. This dual action reduces pain perception and alters consciousness, allowing a quick onset of calming effects when inhaled.

The prescribed dose of nitrous oxide is determined by the treating clinician based on the specific procedure, patient age, weight, and medical condition. Dosage is titrated to achieve the desired level of analgesia and sedation, and is not fixed in the product labeling.

The safety of nitrous oxide during pregnancy and lactation has not been definitively established. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and only under medical supervision.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with agents such as sevoflurane or halothane, nitrous oxide has a rapid onset and recovery, low blood‑gas solubility, and provides analgesic properties. However, it offers weaker muscle relaxation and may require combination with other agents for deeper anesthesia.

The gas cylinders should be stored at ambient temperature, away from direct sunlight and heat sources, and kept in the original packaging to protect the valve. Ensure cylinders are secured upright and handled only by trained personnel.

Nitrous oxide is delivered via a calibrated inhalation system, often using a mask or nasal hood, allowing the patient to breathe a controlled mixture of nitrous oxide and oxygen. Administration is performed by qualified healthcare professionals who monitor the patient’s vital signs throughout the procedure.

The most serious risks include hypoxia, respiratory depression, and cardiovascular instability, especially when nitrous oxide is combined with other depressant drugs. Continuous monitoring of oxygen saturation and vital signs is essential to detect and manage these complications promptly.

Patients with severe chronic obstructive pulmonary disease, uncontrolled asthma, certain vitamin B12 deficiencies, or those who are unable to protect their airway should avoid nitrous oxide. It is also contraindicated in individuals with known hypersensitivity to nitrous oxide or its delivery system components.